Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Recommendation of “Moderate Buy” from Brokerages
Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average […]
More Stories
StockNews.com Begins Coverage on Golden Minerals (NYSE:AUMN)
StockNews.com began coverage on shares of Golden Minerals (NYSE:AUMN – Free Report) in a research note issued to investors on...
StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)
StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Friday. The...
StockNews.com Initiates Coverage on América Móvil (NYSE:AMX)
StockNews.com initiated coverage on shares of América Móvil (NYSE:AMX – Free Report) in a research note released on Friday morning....
Primerica (NYSE:PRI) Rating Increased to Buy at StockNews.com
StockNews.com upgraded shares of Primerica (NYSE:PRI – Free Report) from a hold rating to a buy rating in a research...
Zovio (NYSE:ZVO) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Zovio (NYSE:ZVO – Free Report) in a research note released on Friday. The brokerage...
StockNews.com Begins Coverage on Phoenix New Media (NYSE:FENG)
StockNews.com started coverage on shares of Phoenix New Media (NYSE:FENG – Free Report) in a research note issued to investors...